Outcome of Baerveldt glaucoma implant at Hiroshima University Hospital Ken Kobayashi 1 , Yosuke Sugimoto 2 , Masahide Yanagi 2 , Hideaki Okumichi 2 , Yoshiaki Kiuchi 2 1Department of Ophthalmology, Hori Hospital 2Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University pp.315-321
Published Date 2016/3/15
DOI https://doi.org/10.11477/mf.1410211728
  • Abstract
  • Look Inside
  • Reference

Abstract Purpose: To report the outcome following insertion of Baeveldt glaucoma implant(BGI)at Hiroshima University Hospital.

Cases and Method: This study was made on consecutive series of 56 eyes of 53 cases who received BGI during the past 28 months. All were Japanese citizens and comprised 33 male and 23 female eyes. The age ranged from one to 87 years, average 53 years. Neovascular glaucoma was present in 17 eyes, secondary glaucoma in 16 eyes, and primary open-angle glaucoma in 6 eyes. Glaucoma surgery had been performed at an average of 2.1±2.0 times. Cases were followed up for an average of 12.1 months regarding intraocular pressure(IOP), medication score, corneal endothelial cells, and complications. The outcome was regarded as failure when IOP remained below 5 mmHg or over 22 mmHg, or complications developed needing surgery.

Results: IOP averaged 30.2±9.3 mmHg before and 11.8±3.9 mmHg 12 months after surgery. The difference was significant(p<0.01). Surgery was success in 43 eyes(77%)one year after surgery. The medication score averaged 3.1±0.9 before and 1.2±1.3 12 months after surgery. There was no difference between 40 eyes that received BGI 250 and 16 eyes that received BGI 350. Corneal endothelial cells decreased by an average of 6.3% 6 months after surgery.

Conclusion: BGI was effective in 43 out of 56 Japanese eyes(77%)one year after surgery.

Copyright © 2016, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院